ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Scope & Guideline

Elevating the understanding of arterial health and vascular biology.

Introduction

Welcome to your portal for understanding ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1079-5642
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1990 to 2024
AbbreviationARTERIOSCL THROM VAS / Arterioscler. Thromb. Vasc. Biol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal "Arteriosclerosis, Thrombosis, and Vascular Biology" (ATVB) is dedicated to publishing high-quality research that advances the understanding of vascular biology, particularly in relation to cardiovascular diseases, thrombosis, and atherosclerosis. The journal emphasizes both basic and clinical research, fostering an interdisciplinary approach that incorporates molecular biology, genetics, and epidemiology.
  1. Vascular Biology and Pathophysiology:
    Research focused on the cellular and molecular mechanisms underlying vascular health and disease, including endothelial function, smooth muscle cell dynamics, and the role of vascular inflammation in atherogenesis.
  2. Thrombosis and Hemostasis:
    Investigations into the mechanisms of blood clot formation and resolution, including studies on platelets, coagulation factors, and the impact of various pathological conditions on thrombotic processes.
  3. Atherosclerosis Mechanisms:
    Studies elucidating the pathophysiology of atherosclerosis, including lipid metabolism, inflammatory processes, and the role of immune cells in plaque formation and stability.
  4. Genetic and Environmental Risk Factors:
    Exploration of genetic determinants and environmental influences on cardiovascular disease risk, with a focus on identifying novel biomarkers and therapeutic targets.
  5. Innovative Therapeutic Strategies:
    Research on new therapeutic approaches for cardiovascular diseases, including drug development, gene therapy, and the use of advanced biomaterials for vascular repair.
  6. Translational Research:
    Bridging basic science with clinical applications, aiming to translate findings from laboratory research into effective treatments and interventions for cardiovascular diseases.
The journal has shown a dynamic evolution in its focus areas, with emerging themes reflecting the latest advancements in vascular biology, technology, and clinical practice. These trends indicate a shift towards more integrated and innovative research methodologies.
  1. Precision Medicine Approaches:
    An increasing number of studies focus on personalized medicine, utilizing genetic and molecular profiling to tailor interventions for cardiovascular diseases, reflecting a broader trend in healthcare.
  2. Role of the Microbiome:
    Research exploring the influence of gut microbiota on cardiovascular health is gaining traction, with studies linking microbial metabolites to vascular inflammation and atherosclerosis.
  3. Immunometabolism in Cardiovascular Disease:
    The intersection of immune responses and metabolic processes in vascular disease is emerging as a critical area of research, highlighting the role of inflammation in atherosclerosis and thrombosis.
  4. Innovative Imaging and Biomarker Technologies:
    Advancements in imaging techniques and biomarker discovery are increasingly featured, enabling more precise monitoring of vascular health and disease progression.
  5. Novel Therapeutic Modalities:
    There is a rising interest in novel therapeutic strategies, including the use of nanoparticles, CRISPR technology, and RNA-based therapies, aimed at addressing vascular disease at a molecular level.
  6. Cellular Plasticity and Regenerative Medicine:
    Research on the plasticity of vascular cells and their potential for regeneration and repair is becoming more prominent, particularly in the context of stem cell therapies and tissue engineering.

Declining or Waning

While the journal continues to thrive in many areas, some themes have seen a decline in focus over recent years. These waning scopes may reflect shifts in research priorities or advancements in understanding that have led to saturation in particular topics.
  1. Traditional Risk Factor Studies:
    Research focusing solely on conventional cardiovascular risk factors (e.g., hypertension, cholesterol levels) has decreased as the field moves towards more complex, multifactorial models of disease.
  2. Basic Animal Models:
    There is a noticeable reduction in studies utilizing traditional animal models without incorporating modern techniques such as genetic manipulation or advanced imaging, as researchers seek more relevant and translationally applicable models.
  3. Single-Factor Interventions:
    Research that examines the effects of single interventions on vascular health, without considering the multifaceted interactions present in human health, is becoming less prevalent as the complexity of cardiovascular disease is better appreciated.
  4. Epidemiological Studies with Limited Scope:
    Epidemiological studies that focus narrowly on specific populations without integrating broader systemic factors are declining, as there is a push for more comprehensive approaches to understanding cardiovascular health across diverse populations.

Similar Journals

GENESIS

Exploring Breakthroughs in Medicine and Genetics
Publisher: WILEYISSN: 1526-954XFrequency: 12 issues/year

GENESIS is a renowned journal dedicated to advancing the fields of Cell Biology, Endocrinology, Genetics, and Miscellaneous Medicine, published by WILEY. With an ISSN of 1526-954X and an E-ISSN of 1526-968X, this journal has established a significant presence in academic publishing since its inception in 2000. Positioned within the Q3 category for Cell Biology and Q2 categories for Endocrinology, Genetics, and Medicine in the 2023 rankings, GENESIS offers an interdisciplinary platform that fosters pioneering research and innovation. Additionally, the journal provides options for Open Access, ensuring that vital discoveries are accessible to a broader audience. Researchers, professionals, and students alike will find valuable insights and cutting-edge studies within its pages, making GENESIS a crucial resource for anyone invested in the biological sciences.

Current Opinion in Physiology

Connecting Researchers to the Pulse of Physiology
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

Current Opinion in Physiology, published by Elsevier, is a leading journal dedicated to the dynamic field of physiology. With an E-ISSN of 2468-8673, this journal provides a platform for the latest insights and perspectives, reflecting the evolving landscape of physiological research. Operating from the United Kingdom, the journal holds a respectable impact factor and is ranked Q2 in both general physiology and medical physiology categories, highlighting its prominence among the global academic community. With Scopus rankings placing it in the 64th and 60th percentiles within its respective categories, Current Opinion in Physiology serves as an essential resource for researchers, professionals, and students eager to stay informed about innovative theories and emerging trends in physiology. The publication emphasizes high-quality reviews that summarize current knowledge and future directions, ensuring readers gain valuable insights applicable in both clinical and research settings.

Annals of Vascular Diseases

Connecting Ideas, Advancing Vascular Treatments
Publisher: ANNALS VASCULAR DISEASES EDITORIAL OFFICEISSN: 1881-641XFrequency: 4 issues/year

Annals of Vascular Diseases is a leading international journal dedicated to the comprehensive exploration of vascular pathology, aimed at advancing knowledge in the field through innovative research and insightful reviews. Published by the ANNALS VASCULAR DISEASES EDITORIAL OFFICE and available in both print (ISSN: 1881-641X) and electronic format (E-ISSN: 1881-6428), this journal has embraced Open Access since 2017, facilitating wider dissemination and accessibility of vital research findings. With its focus on clinical and experimental studies relating to vascular diseases, the journal serves as a crucial platform for researchers, medical professionals, and students who seek to stay at the forefront of clinical advancements. By fostering collaboration and sharing knowledge, Annals of Vascular Diseases plays a significant role in shaping the future of vascular research and treatment strategies worldwide.

International Journal of Angiology

Exploring innovative insights in angiology and cardiology.
Publisher: THIEME MEDICAL PUBL INCISSN: 1061-1711Frequency: 4 issues/year

Welcome to the International Journal of Angiology, a distinguished publication dedicated to advancing the field of cardiology and cardiovascular medicine. Published by THIEME MEDICAL PUBL INC, this journal plays a crucial role in disseminating innovative research and clinical insights from 1992 through 2024, serving as a vital resource for researchers, healthcare professionals, and students alike. With an ISSN of 1061-1711 and an E-ISSN of 1615-5939, the journal currently holds a respectable Q4 ranking in the cardiology field, reflecting its commitment to quality and relevance. Although it operates under a traditional access model, the journal ensures that critical research findings are shared with a broad audience, fostering collaboration and knowledge exchange. By exploring current trends, diagnostic techniques, and treatment modalities in angiology, the International Journal of Angiology remains an essential platform for those dedicated to improving cardiovascular health around the globe.

CIRCULATION RESEARCH

Elevating knowledge in the dynamic field of cardiovascular medicine.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7330Frequency: 24 issues/year

CIRCULATION RESEARCH is a premier journal dedicated to advancing the field of cardiovascular science, focusing on innovative research in cardiology and physiology. Published by Lippincott Williams & Wilkins, this esteemed journal has been a cornerstone of cardiovascular research since its inception in 1953, maintaining rigorous standards of scholarly excellence. With an impressive impact factor and ranking in the top quartiles for both Cardiology and Cardiovascular Medicine (Q1) and Physiology (Q1), it holds a significant position in the Scopus database. This journal features cutting-edge studies aimed at understanding the mechanisms of cardiovascular health and disease, promoting the translation of research into clinical practice. Weekly issues provide practitioners and researchers alike with vital insights to keep abreast of the latest developments. Although it does not offer open access, CIRCULATION RESEARCH remains vital for professionals striving to enhance their knowledge and impact in the ever-evolving landscape of cardiovascular medicine.

Journal of Atherosclerosis and Thrombosis

Shaping the future of cardiovascular care with cutting-edge insights.
Publisher: JAPAN ATHEROSCLEROSIS SOCISSN: 1340-3478Frequency: 12 issues/year

Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.

VASCULAR PHARMACOLOGY

Elevating the standards of vascular pharmacological research.
Publisher: ELSEVIER SCIENCE INCISSN: 1537-1891Frequency: 12 issues/year

Vascular Pharmacology, published by Elsevier Science Inc, is a leading journal in the fields of pharmacology and molecular medicine, dedicated to advancing our understanding of vascular biology and therapeutic interventions. With an impressive impact factor reflecting its significant contribution to the scientific community, this journal seeks to publish ground-breaking research that elucidates the molecular mechanisms underlying vascular function and disease, as well as the pharmacological impact of new therapeutic agents. The journal operates under a dual access model, allowing for both subscription and open access options, ensuring that vital research is accessible to a wide audience. As of 2023, it holds a prestigious position in the Q1 category for pharmacology and ranks well in molecular medicine and physiology, reflecting its high quality and relevance. Whether you are a researcher, clinician, or student, Vascular Pharmacology serves as an essential resource to stay at the forefront of cardiovascular pharmacotherapy and vascular biology.

ANGIOGENESIS

Exploring the Frontiers of Angiogenesis Research
Publisher: SPRINGERISSN: 0969-6970Frequency: 4 issues/year

ANGIOGENESIS is a prestigious academic journal published by Springer, focusing on the vital field of angiogenesis research, a cornerstone in understanding tumor biology and tissue regeneration. Established in 1997 and continuously evolving, this journal has solidified its reputation, ranking in the Q1 category for Cancer Research, Clinical Biochemistry, and Physiology as of 2023. With an impressive impact factor, it serves as an essential platform for disseminating cutting-edge research findings, critical reviews, and novel methodologies. ANGIOGENESIS is indexed in high-impact databases and exhibits exceptional Scopus ranks—1st in Clinical Biochemistry, 6th in Physiology, and 14th in Cancer Research, underscoring its significant contribution to the scientific community. Although it does not currently offer open access options, it ensures that all articles maintain rigorous peer-review standards to meet the highest academic excellence. Researchers, professionals, and students alike will find ANGIOGENESIS to be an invaluable resource in advancing their knowledge and research in the intricate mechanisms of vascular biology.

International Heart Journal

Connecting Researchers to Enhance Cardiovascular Care
Publisher: INT HEART JOURNAL ASSOCISSN: 1349-2365Frequency: 6 issues/year

International Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.

Vascular Health and Risk Management

Fostering collaboration to enhance vascular health understanding.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1176-6344Frequency: 1 issue/year

Vascular Health and Risk Management is a leading peer-reviewed journal published by DOVE MEDICAL PRESS LTD, focusing on the critical areas of cardiology, endocrinology, and public health. With an impact factor that reflects its significance within the scientific community, this Open Access journal, established in 2005, has been committed to enhancing knowledge on the interplay between vascular health and various risk factors affecting patient outcomes. The journal is proudly based in New Zealand and is indexed across multiple categories, maintaining a prominent Q2 ranking in cardiology, endocrinology, diabetes, and several other medical disciplines as of 2023. By providing a platform for innovative research and comprehensive reviews, Vascular Health and Risk Management seeks to foster collaboration among healthcare professionals, enhance clinical practices, and ultimately improve patient care through rigorous scientific inquiry and disseminated knowledge. Researchers, professionals, and students will find invaluable insights that inform their work and advance the understanding of vascular-related health issues.